Cancer and Metastasis Reviews

1.8k papers and 129.5k indexed citations i.

About

The 1.8k papers published in Cancer and Metastasis Reviews in the last decades have received a total of 129.5k indexed citations. Papers published in Cancer and Metastasis Reviews usually cover Molecular Biology (906 papers), Oncology (791 papers) and Cancer Research (530 papers) specifically the topics of Cancer Cells and Metastasis (212 papers), Cancer, Hypoxia, and Metabolism (185 papers) and Cancer Genomics and Diagnostics (139 papers). The most active scholars publishing in Cancer and Metastasis Reviews are Kenneth V. Honn, Robert S. Kerbel, David G. Menter, Isaiah J. Fidler and Razelle Kurzrock.

In The Last Decade

Fields of papers published in Cancer and Metastasis Reviews

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Cancer and Metastasis Reviews. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Cancer and Metastasis Reviews

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Cancer and Metastasis Reviews. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Cancer and Metastasis Reviews with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025